Early expression of interleukin-12, p40 subunit and IFN-γ inhibits regression of AK-5 tumor

Cytokines, Cellular and Molecular Therapy

Volumn 3, Issue 4, 1997, Pages 225-232

  Nandakumar, K S ^a   Leela Kumari, A ^a   Khar, Ashok ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

Th1 cytokines; Tumor regression

Indexed keywords

CELL PROTEIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; PROTEIN P40; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CANCER SURVIVAL; CANCER TRANSPLANTATION; CELL ACTIVATION; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HELPER CELL; HISTIOCYTOMA; IMMUNE RESPONSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REMISSION; SPLEEN CELL; TRANSLATION REGULATION; TUMOR CELL; TUMOR REGRESSION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, NEOPLASM; ANTINEOPLASTIC AGENTS; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTIOCYTOMA, BENIGN FIBROUS; IMMUNE SERA; INTERFERON TYPE II; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-2; NEOPLASM REGRESSION, SPONTANEOUS; NEOPLASM TRANSPLANTATION; RATS; RATS, WISTAR; RECEPTORS, INTERLEUKIN-2; RECOMBINANT PROTEINS; RNA; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 9844250750     PISSN: 13684736     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Melief CJM, Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv Cancer Res (1992) 58: 143-75.
2. Khar A, Kausalya S, Kamal MA, AK-5 tumor-induced modulation of host immune function: upregulation of Th-1-type cytokine response mediates early tumor regression. Cytokines Mol Ther (1996) 2: 39-46.
3. Mosmann TR, Coffman RL, Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol (1989) 7: 145-73.
4. Zier K, Gansbacher B, Salvadori S, Preventing abnormalities in signal transduction of T cells in cancer: the promise of cytokine gene therapy. Immunol Today (1996) 17: 39-45.
5. Musiani P, Modesti A, Giovarelli M et al, Cytokines, tumour-cell death and immunogenicity: a question of choice. Immunol Today (1997) 18: 32-6.
6. Liu Y, Linsley PS, Costimulation of T cell growth. Curr Opin Immunol (1992) 4: 265-70.
7. Tripp CS, Wolf SE, Unanue ER, Interleukin-12 and tumor necrosis factor α are co-stimulators of interferon-γ production by natural killer cells in severe combined immuno-deficiency mice with listeriosis, and interleukin-10 is a physiologic antagonist. Proc Natl Acad Sci USA (1993) 90: 3725-9.
8. Rosenberg SA, Lotz MT, Muul LM et al, Observations on the systemic administration of autologous lymphokine activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med (1985) 313: 1485-92.
9. Kärre K, Hansson M, Kiessling R, Multiple interactions at the natural killer workshop. Immunol Today (1991) 12: 343-45.
10. Smith KA, Cantrell DA, Interleukin-2 regulates its own receptors. Proc Natl Acad Sci USA (1985) 82: 864-8.
11. Ortaldo JR, Mason AT, Gerard JP et al, Effects of natural and recombinant IL-2 on regulation of IFN production and natural killer activity: lack of involvement of the TAG antigen for these immunoregulatory effects. J Immunol (1984) 133: 779-83.
12. Perussia B, Lymphokine activated killer cells, natural killer cells and Cytokines. Curr Opin Immunol (1991) 3: 49-55.
13. Trinchieri G, Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol (1995) 13: 251-76.
14. Wigginton JM, Komschlies KL, Back TC et al, Administration of interleukin-12 with pulse interleukin-2 and the rapid and complete eradication of murine renal carcinoma. J Natl Cancer Inst (1996) 88: 38-43.
15. Mattner F, Fischer S, Guckes S et al, The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer. Eur J Immunol (1993) 23: 2202-8.
16. Gillessen S, Carvajal D, Ling P et al, Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur J Immunol (1995) 25: 200-6.
17. Kausalya S, Varalakshmi C, Khar A, Correlation of in vitro and in vivo effects of interferon-γ with the spontaneous regression of a rat histiocytoma. J Interferon Cytokine Res (1995) 15: 647-54.
18. Khar A, Development and characterization of a rat histiocyte-macrophage tumor line. J Natl Cancer Inst (1986) 76: 871-8.
19. Khar A, Characterization of spontaneous immunological regression in a histiocytoma: I. Role of NK cells and antitumor antibodies. Int J Oncol (1993) 2: 393-8.
20. Khar A, Leela Kumari A, Ali AM, Characterization of spontaneous immunological regression in a histiocytoma: II. Participation of tumor necrosis factor. Int J Oncol (1993) 2: 399-402.
21. Kausalya S, Hegde SP, Bright JJ, Khar A, Mechanism of antibody-dependent natural killer cell-mediated AK-5 tumor cell death. Exp Cell Res (1994) 212: 285-90.
22. Khar A, Ali AM, Adaptation of rat histiocytoma cells AK-S to growth in culture. In Vitro Cell Dev Biol (1990) 26: 1024-5.
23. Chomezynski P, Sacchi N, Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal Biochem (1987) 162: 156-9.
24. Sambrook J, Fritsch EF, Maniatis T, Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1989.
25. Church GM, Gilbert W, Genomic sequencing. Proc Natl Acad Sci USA (1984) 81: 1991-5.
26. Khar A, Varalakshmi Ch, Pardhasaradhi, BVV, Mubarak Ali A, Generation of cytotoxic monoclonals against AK-5 histiocytoma: conjugation with daunomycin and use in chemotherapy. Cancer Lett (1992) 64: 163-9.
27. Ijsselmuiden OE, Herbrink P, Meddens MJM et al, Optimizing the solid-phase immunofiltration assay: a rapid alternative to immunoassays. J Immunol Meth (1989) 119: 35-43.
28. Bette M, Jin S, Germann T et al, Differential expression of mRNA encoding interleukin-12 p35 and p40 subunits in situ. Eur J Immunol (1994) 24: 2435-40.
29. Hegde SP, Bright JJ, Kausalya S, Khar A, AK-5 tumor induced expression of IL-12: role of IL-12 in AK-5 regression. Cell Immunol (1995) 162: 241-7.
30. Akbar AN, Salmon M, Cellular environments and apoptosis: tissue microenvironments control activated T-cell death. Immunol Today (1997) 18: 72-6.
31. Armant M, Delespesse G, Sarfati M, IL-2 and IL-7 but not IL-12 protect natural killer cells from death by apoptosis and upregulate bcl-2 expression. Immunology (1995) 85: 331-7.
32. Schmitz J, Assenmacher M, Radbruch A, Regulation of T helper cell cytokine expression: functional dichotomy of antigen-presenting cells. Eur J Immunol (1993) 23: 191-9.
33. Daynes RA, Araneo BA, Dowell TA et al, Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. J Exp Med (1990) 171: 979-96.
34. Meeusen ENT, Premier RR, Brandon MR, Tissue-specific migration of lymphocytes: a key role for Th1 and Th2 cells? Immunol Today (1996) 17: 421-4.
35. Orange JS, Biron CA, Characterization of early IL-12, IFN-α, β, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J Immunol (1996) 156: 4746-56.
36. Sundstrom JB, Ansari AA, Comparative study of the role of professional versus semiprofessional and non-professional antigen presenting cells in the rejection of vascularized organ allografts. Transplant Immunol (1995) 3: 273-89.
37. Lopez-Botet M, Moretta L, Strominger J, NK-cell receptors and recognition of MHC class I molecules. Immunol Today (1996) 17: 212-4.